Progression-free survival was improved among patients who received nivolumab and ipilimumab, and toxicity was generally greater among patients who received chemotherapy.

This page includes links to articles highlighting the top lung cancer research published on Cancer Therapy Advisor in 2024.

Cancer patients may require COVID-19 vaccinations more often than the general public, but oncology-specific vaccination guidance is needed, researchers say.